期刊文献+

进行性色素性紫癜性皮病27例临床分析 被引量:7

Clinical Analysis of 27 Cases of Progressive Pigmented Purpuric Dermatosis
下载PDF
导出
摘要 目的探讨进行性色素性紫癜性皮病的发病原因、临床特点和治疗方案,提高对本病的认识。方法回顾性分析本科1995年1月-2010年10月收治的27例进行性色素性紫癜性皮病患者的临床和实验室检查资料。结果 27例患者中男女比例为1.7:1,15例(55.56%)合并有基础疾病。18例(66.67%)皮损位于双下肢,6例患者(22.22%)累及四肢,3例患者(11.11%)累及四肢、臀部和躯干,糖皮质激素、雷公藤多甙、沙利度胺、氨苯砜等不同药物联合治疗后21例患者皮损消退,6例患者皮损大部分消退。其中19例患者出现反复复发。结论进行性色素性紫癜性皮病病程慢性、易复发,目前尚无特效治疗;糖皮质激素、雷公藤多甙、沙利度胺、氨苯砜等治疗均有效,且以糖皮质激素效果明显,但不能预防复发,光疗可作为一有效而安全的联合或单独治疗选择。 Objective To improve the recognition of clinical feature of progressive pigmented purpuric dermatosis (Schambergs' disease). Methods The clinical data of 27 cases of progressive pigmented purpuric dermato- sis collected from dermatology department of the First Affiliated Hospital of Kunming Medical College from January 1995 to October 2010, were retrospectively analyzed on their etiology ,clinical features and efficiency of treatment retrospectively. Results The results showed ratio of male/female was 1.7: 1, and fifteen cases (55.56%) had other underlying diseases. Lesions of 18 patients were limited on the lower extremity (66.67%), lesions of 6 patients were involved with their extremitis (22. 22%), 3 patients' lesions ( 11.11% )located disseminatedly. Patients responded to the combinations of the various drugs including corti- costeroid, tripterygium hypoglaucum, thalidone, DDS, and so on. Lesions of 21 cases cleared, lesions of 6 cases cleared considerably and 19 cases recurred repeatedly. Conclusion The disease usually runs a chronic and relapsing course. Glucocorticoid, ripterygium hypoglaucum, thalidone, and DDS are the main therapeutic drugs for Schambergs' disease, but they can't prevent recurrences. Glucocorticoid is effective but is not recommend as the first choice. Narrowband UVB can be a good alternative in the treatment of Schambergs' disease.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2011年第6期448-449,456,共3页 The Chinese Journal of Dermatovenereology
关键词 进行性色素性紫癜性皮病 临床分析 Progressive pigmented purpuric dermatosis Clinical analysis
  • 相关文献

参考文献8

  • 1Sardana K,Sarkar R,Sehgal VN. Pigmented purpuric demlatoses: an o- verview[ J]. Int J Dermatol, 2004, 43(7) : 482 -488. 被引量:1
  • 2Torrelo A,Requena C,Mediero IG,et al. Schamberg's purpura in children- a review of 13 cases[J]. J Am Acad Dermatol,2003,48(1 ) :31 -33. 被引量:1
  • 3de Godoy JM, Batigalia F. Aminaphtone in the control of Schamberg's disease[J]. Thromb J, 2009, 7: 8. 被引量:1
  • 4Magro CM, Schaefer JT, Crowson AN, et al. Pigmented purpuric der- matosis: classification by phenotypic and molecular profiles[ J ]. Am J Clin Pathol, 2007, 128(2) : 218 -229. 被引量:1
  • 5Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric derma- titis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy, and molecular methods[ J]. Am J Dermatopathol, 1997, 19(2): 108-118. 被引量:1
  • 6Satoh T, Yokozeki H, Nishioka K. Chronic pigmented purpura associat- ed with odontogenic infection [ J]. J Am Acad Dermatol, 2002, 46 ( 6 ) : 942 - 944. 被引量:1
  • 7Seckin D, Yazici Z, Senol A, et al. A case of Schamberg's disease re- sponding dramatically to PUVA treatment [ J]. Photodermatol Photoim-munol Photomed, 2008, 24 (2) : 95 - 96. 被引量:1
  • 8Gudi VS, White MI. Progressive pigmented purpura (Schamberg's dis- ease) responding to TL01 ultraviolet B therapy[ J]. Clin Exp Dermatol, 2004, 29(6) : 683 -684. 被引量:1

同被引文献31

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部